Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS
LetterLetter

Benign Pneumatosis Intestinalis in a Patient with Juvenile Dermatomyositis

ROBERTA BERARD, GAËLLE CHÉDEVILLE, CHRISTINE SAINT-MARTIN and ROSIE SCUCCIMARRI
The Journal of Rheumatology November 2010, 37 (11) 2442-2444; DOI: https://doi.org/10.3899/jrheum.100537
ROBERTA BERARD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GAËLLE CHÉDEVILLE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTINE SAINT-MARTIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROSIE SCUCCIMARRI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rosie.scuccimarri@muhc.mcgill.ca
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

To the Editor:

Juvenile dermatomyositis (JDM) is an autoimmune vasculopathy involving primarily the proximal muscles and skin but can involve other organ systems, particularly the gastrointestinal (GI) tract1. In the presence of cutaneous vasculitic ulcerations, one needs to monitor for signs and symptoms suggestive of GI vasculopathy2, which can lead to bowel ischemia, necrosis, ulceration, and perforation1,2,3,4,5. The presence of gas in the bowel wall, also referred to as pneumatosis intestinalis (PI), is an ominous finding when it is due to a GI vasculopathy3. PI is a radiographic finding that is associated with both benign and life-threatening causes. The benign variant of PI has been described in relation to immunosuppressive therapy6 and to JDM itself7. We describe a child with JDM complicated by cutaneous ulcerations and benign PI.

An 8-year-old girl, following a 1-month history of rash and fatigue, was diagnosed with JDM based on the presence of Gottron sign, heliotrope rash, symmetric proximal muscle weakness, elevated serum muscle enzymes [creatine kinase (CK) 533 U/l (normal 44–189); lactate dehydrogenase 442 U/l (normal 142–261); aldolase 9.3 U/l (normal 0–7.6)] and findings consistent with myositis on magnetic resonance imaging of the proximal hip and shoulder girdle muscles. Antinuclear and anti-Jo1 antibodies were negative. The initial Childhood Myositis Assessment Scale8 (CMAS) was 44/52. Her nailfold capillaries were normal. Initial treatment included high-dose oral corticosteroids and methotrexate (MTX).

Three weeks after starting therapy, she presented with increased weakness, a vasculitic ulcer on the left upper eyelid and in the left nare associated with an increase in CK (1170 U/l); however, the other muscle enzymes remained unchanged. She was treated with intravenous pulse methylprednisolone once daily for 3 days. When reassessed a few days later for a cough, a chest radiograph showed free air under the right hemidiaphragm (Figure 1). She was asymptomatic. The eyelid and nare ulcers were healing, with no new cutaneous ulcerations. Her muscle strength (CMAS 46/52) had improved. Her abdomen was slightly distended but soft, non-tender with present bowel sounds. A pneumoperitoneum and extensive PI, primarily involving the large bowel, were confirmed by computed tomography (CT) of the abdomen (Figures 2 and 3). No associated signs of bowel wall thickening, fat stranding, or abdominal free fluid were present.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Free air under the right hemidiaphragm (arrow).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Infused CT scan of the abdomen, coronal view, showing extensive pneumatosis intestinalis in the large colon.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Infused CT scan of the abdomen, axial view, showing circumferential pneumatosis intestinalis of the transverse colon.

The patient was admitted to hospital for intravenous antibiotics and a short period of bowel rest. Additional investigations included a normal complete blood cell count, blood gas, lactic acid, fibrinogen, and coagulation profile. The muscle enzymes had improved with normalization of CK (52 U/l). D-dimers were negative; however, the von Willebrand factor antigen was elevated at 4.9 U/ml (normal 0.5–1.6). Anticardiolipin antibodies and lupus anticoagulant were negative. Family history was negative for vascular diseases. There was no escalation in immunosuppressive therapy. She remained asymptomatic and was discharged after 10 days without adverse sequelae. An abdominal radiograph performed 6 weeks later demonstrated persistence of PI with resolution of the pneumoperitoneum. The rest of her course was uncomplicated. Prednisone was discontinued 14 months from diagnosis and she continues on a tapering dose of MTX.

PI was first described in 17549. It is defined as the presence of gas within the bowel wall10 and is a radiographic finding that can be seen with many diagnostic entities11. The prevalence of PI is not known; however, this seems to be increasing with more frequent use of CT and immunosuppressive therapy10,12.

Benign causes of PI have been described in relation to systemic illness (collagen vascular disease, chronic pulmonary disease), medications, and GI procedures10,12. In 1973, Borns and Johnston suggested a link between PI and immunosuppressive therapy, particularly corticosteroids6. On pathologic specimens, air was discovered in the Peyer patches of the intestine13. This led to the hypothesis that steroids or stress cause lymphoid depletion and thus atrophy of the Peyer patches, resulting in alteration of the submucosal structural integrity, which permits intraluminal gas to dissect into the noninflamed bowel wall6,10,11,12.

The life-threatening causes of PI are those associated with bowel necrosis. In JDM, bowel necrosis occurs as a consequence of the vasculopathy1. A review in 1998 identified 6 patients in the literature with PI associated with JDM4; 4 had a benign clinical course similar to our patient, 1 had a life-threatening course, and 1 patient died4. In JDM, it is imperative to promptly identify a GI vasculopathy, as this can be fatal.

Cutaneous ulcerative disease in JDM may be associated with more widespread vasculitis and thus PI seen in this context would more commonly be secondary to bowel necrosis. Despite the cutaneous ulcerations in our patient, she did not have life-threatening PI. Pneumoperitoneum, as observed in our patient, can also occur in benign PI, which in this context is usually the consequence of the rupture of a subserosal cyst rather than a true perforation10,12. Worrisome features on imaging include signs of bowel wall inflammation or ischemia manifesting as bowel wall thickening, free fluid, or portal gas12, which were absent in our case.

The management of PI depends on the underlying etiology and most importantly on the clinical condition of the child. In the absence of sepsis or peritonitis, many children can be managed conservatively with antibiotic coverage and bowel rest10. The presence of PI alone is not an indication for surgical intervention or escalation of medical therapy. However, in children with a clinical deterioration, surgical intervention may be warranted10.

Our patient was asymptomatic and did not have the more worrisome features on imaging. Her presentation and clinical course, in our opinion, were consistent with benign PI, which we presumed was secondary to immunosuppressive therapy. However, we could not exclude the presence of a mild vasculopathy resulting in loss of mucosal integrity, given the elevated von Willebrand factor antigen. Both the benign and life-threatening variants of PI should be considered, particularly in patients at high risk for bowel necrosis.

Increased awareness of the benign form of PI in combination with clinical history, physical examination, and laboratory and radiographic evaluations will allow proper identification of this entity, which may prevent unnecessary escalation in medical therapy and/or surgical intervention.

REFERENCES

  1. 1.↵
    1. Feldman BM,
    2. Rider LG,
    3. Reed AM,
    4. Pachman LM
    . Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008;371:2201–12.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Meneghel A,
    2. Zulian F,
    3. Martini G,
    4. Guariso G
    . Ischemic ulcerative colitis in juvenile dermatomyositis. J Pediatr Gastroenterol Nutr 2009;49:549.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Fischer TJ,
    2. Cipel L,
    3. Stiehm ER
    . Pneumatosis intestinalis associated with fatal childhood dermatomyositis. Pediatrics 1978;61:127–30.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Stefanski JC,
    2. Shetty AK
    . Abdominal pain in a girl with juvenile dermatomyositis. Clin Pediatr 1998;37:561–4.
    OpenUrlFREE Full Text
  5. 5.↵
    1. Mamyrova G,
    2. Kleiner DE,
    3. James-Newton L,
    4. Shaham B,
    5. Miller FW,
    6. Riser LG
    . Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration from chronic endarteropathy. Arthritis Rheum 2007;57:881–4.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Borns PF,
    2. Johnston TA
    . Indolent pneumatosis of the bowel wall associated with immune suppressive therapy. Ann Radiol 1973;16:163–6.
    OpenUrl
  7. 7.↵
    1. Braunstein EM,
    2. White SJ
    . Pneumatosis intestinalis in dermatomyositis. Br J Radiol 1980;53:1011–2.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Huber AM,
    2. Feldman BM,
    3. Rennebohm RM,
    4. Hicks JE,
    5. Lindsley CB,
    6. Perez MD,
    7. et al.
    Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004;50:1595–603.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Koss LG
    . Abdominal gas cysts (pneumatosis cystoides intestinorum hominis): an analysis with a report of a case and a critical review of the literature. Arch Pathol 1952;53:523–49.
    OpenUrl
  10. 10.↵
    1. Fenton LZ,
    2. Buonomo C
    . Benign pneumatosis in children. Pediatr Radiol 2000;30:786–93.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Pear BL
    . Pneumatosis intestinalis: a review. Radiology 1998;207:13–9.
    OpenUrlPubMed
  12. 12.↵
    1. Ho LM,
    2. Paulson EK,
    3. Thompson WM
    . Pneumatosis intestinalis in the adult: benign to life-threatening causes. AJR Am J Roentgenol 2007;188:1604–13.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Smith BH,
    2. Welter LH
    . Pneumatosis intestinalis. Am J Clin Pathol 1967;48:455–65.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 37, Issue 11
1 Nov 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Benign Pneumatosis Intestinalis in a Patient with Juvenile Dermatomyositis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Benign Pneumatosis Intestinalis in a Patient with Juvenile Dermatomyositis
ROBERTA BERARD, GAËLLE CHÉDEVILLE, CHRISTINE SAINT-MARTIN, ROSIE SCUCCIMARRI
The Journal of Rheumatology Nov 2010, 37 (11) 2442-2444; DOI: 10.3899/jrheum.100537

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Benign Pneumatosis Intestinalis in a Patient with Juvenile Dermatomyositis
ROBERTA BERARD, GAËLLE CHÉDEVILLE, CHRISTINE SAINT-MARTIN, ROSIE SCUCCIMARRI
The Journal of Rheumatology Nov 2010, 37 (11) 2442-2444; DOI: 10.3899/jrheum.100537
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Save to my folders

Jump to section

  • Article
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Rapidly Progressive Systemic Sclerosis–associated Interstitial Lung Disease After Intravesical Bacillus Calmette-Guérin Therapy for Early-stage Bladder Cancer
  • Axial Involvement in Psoriatic Arthritis: Effect on Peripheral Arthritis and Differential Features With Axial Spondyloarthritis in South America
  • The Effect of HLA-B27 on Susceptibility and Severity of COVID-19
Show more Letters

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2016 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire